Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study
- PMID: 33089907
- DOI: 10.1002/hup.2764
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study
Abstract
Objective: This study aims to clarify the relevant factors influencing practitioners' methods of prescribing medications for bipolar disorder, in a nation-wide survey in Japan.
Methods: The clinical records of 3130 outpatients with bipolar disorder were consecutively reviewed from 176 psychiatric outpatient clinics. Fifteen parameters, that is, five patients' including five general characteristics (sex, age, education, occupation, and social adjustment), five patients' aspects of mental functioning (onset age, comorbid mental illness, rapid-cycling, psychopathologic severity, and followed-up years), and five practitioners' characteristics (sex, age, specialist experience, clinic standing years, and location), were evaluated. The number of psychotropic drugs (mood stabilizers, antidepressants, antipsychotic drugs, anxiolytics, and hypnotics) was used as an index of pharmacotherapy. Converted data from each practitioner-unit were analyzed.
Results: Seven factors (patient's social adjustment, patient's psychopathology, patient's comorbid mental disorders, patient's followed-up years, doctor's age, clinic running years, and patient's education years) were correlated to the number of psychotropic drugs. Multiple regression analysis showed that the severity of illness (poor social adjustment, and comorbid mental illness) and an intractable disease course (long followed-up years), were significantly associated with the number of psychotropic drugs.
Conclusion: Our findings indicated that patient-related conditions affected psychotropic polypharmacy more strongly than did practitioner-related conditions.
Keywords: bipolar disorder; course of disease; polypharmacy; prescribing manners; psychosocial function; psychotropic drugs.
© 2020 John Wiley & Sons Ltd.
References
REFERENCES
-
- Adachi, N. , Kubota, Y. , Goto, E. , Ueda, H. , Azekawa, T. , Hongo, S. , … Watanabe, Y. (2016). Numbers of patients with mood disorder in JAPC clinics: Assumption and interpretation from the collaboration study preliminary survey. Journal of Japanese Association of Psychiatric Clinics, 42, 7-9 (in Japanese).
-
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, DSM-IV-TR, text revision (4th ed.). Arlington, TX: American Psychiatric Association.
-
- Baldessarini, R. , Henk, H. , Sklar, A. , Chang, J. , & Leahy, L. (2008). Psychotropic medications for patients with bipolardisorder in the United State: Polytherapy and adherence. Psychiatric Services, 59, 1175-1183.
-
- Bauer, M. , Glenn, T. , Alda, M. , Sagduyu, K. , Marsh, W. , Grof, P. , … Whyblow, P. C. (2013). Drug treatment patterns in bipolar disorder: Analysis of long-term self-reported data. International journal of bipolar disorders, 1, 5. https://doi.org/10.1186/2194-7511-1-5
-
- Bortolasci, C. C. , Spolding, B. , Callaly, E. , Martin, S. , Pnizzutti, B. , Kidnapillai, S. , … Walder, K. (2018). Mechanisms underpinning the polypharmacy effects of medications in psychiatry. The International Journal of Neuropsychopharmacology, 21, 582-591.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
